dolutegravir 50 MG / lamivudine 300 MG Oral Tablet [Dovato]
RxNorm concept 2122526, branded drug (sbd). Prescribable name: Dovato 50 MG / 300 MG Oral Tablet.
- RxCUI
- 2122526
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2122526 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Dovato (dolutegravir 50 MG (equivalent to 52.6 MG dolutegravir sodium) / lamiVUDine 300 MG) Oral Tablet; Dovato (dolutegravir 50 MG (equivalent to 52.6 MG dolutegravir sodium) / lamivudine 300 MG) Oral Tablet; dolutegravir 50 MG / 3TC 300 MG Oral Tablet [Dovato]; dolutegravir 50 MG / lamiVUDine 300 MG Oral Tablet [Dovato]
Related concepts
- lamivudine 300 MG (SCDC, consists of)
- dolutegravir 50 MG (SCDC, consists of)
- dolutegravir 50 MG / lamivudine 300 MG [Dovato] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Dovato (BN, has ingredient)
- dolutegravir 50 MG / lamivudine 300 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2122526 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2122526 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2122526. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.